Omeros (OMER) – Corporate News
-
Omeros (OMER) Appoints Andreas Grauer as Chief Medical Officer
-
Omeros (OMER) says narsoplimab did not achieve statistically significant improvement over placebo in Phase 3 trial
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to OMER Stock Lookup